Invivoscribe (@Invivoscribe) header
Invivoscribe (@Invivoscribe) profile picture

Invivoscribe

@Invivoscribe

Improving lives with precision diagnostics® for informed treatment decisions in myelo- and lympho-proliferative disorders. #Oncology #MFC #NGS #ClinicalTrials

 San Diego, CA, USA
invivoscribe.com
Joined March 2010
  • Tweets1.8K
  • Following703
  • Followers551
643Media
Photo by Invivoscribe (@Invivoscribe)Photo by Invivoscribe (@Invivoscribe)Photo by Invivoscribe (@Invivoscribe)Photo by Invivoscribe (@Invivoscribe)Photo by Invivoscribe (@Invivoscribe)Photo by Invivoscribe (@Invivoscribe)Photo by Invivoscribe (@Invivoscribe)Photo by Invivoscribe (@Invivoscribe)Photo by Invivoscribe (@Invivoscribe)Photo by Invivoscribe (@Invivoscribe)
How can multiparameter flow cytometry (MFC) and next-generation sequencing (NGS) work together to improve AML patient care? Learn practical strategies for MRD assessment in a FREE webinar on July 30 at 2 p.m. ET sponsored by @Invivoscribe. Register: bit.ly/4wscLWI
Online workshop on integrating new AML guidelines using multiparameter flow cytometry and NGS MRD for treatment decisions, featuring expert speakers.

ALT Online workshop on integrating new AML guidelines using multiparameter flow cytometry and NGS MRD for treatment decisions, featuring expert speakers.

5
5
376
Relapse is a major obstacle to recovery from acute myeloid leukemia (AML). The Biomarkers Consortium announces a project validating measurable residual disease (MRD) as a biomarker to assess patient disease status and inform treatment efforts. Read more: fnih.org/news/announcements/…
Image from Foundation for the National Institutes of Health (@FNIH_Org)
5
11
6
28
Join us on 4/17 at 1:00 pm ET for a free Online Corporate Workshop on NGS Clonality Assays with Bioinformatics. This event is sponsored by @Invivoscribe. We hope to see you there! ow.ly/QqVA30ju1QZ
Image from Association for Molecular Pathology (@AMPath)
1
1
Acute myeloid leukemia (AML) is a kind of cancer that affects the blood & bone marrow. #AML is characterized by the rapid production & growth of abnormal blood cells, which can build up in the bone marrow & prevent the production of normal blood cells #KnowAML #awareness
Image from Know AML 🔴⚫️ (@KNOW_AML)
1
8
11
Listen to several talks - J.Miller & T.Stenzel @Invivoscribe, Mark Levis @JohnsHopkins - focusing on "Precision diagnostics, the critical evolution in #precisionmedicine, necessary to optimize therapies and demonstrate optimal drug performance" at #PMWC18 vimeo.com/253194765
1
1
3
#PMWC18: Session now on Internationally Standardized #Assays to Monitor Treatment & Residual Disease ow.ly/AnhA30hUyuG Jeffrey Edward Miller @Invivoscribe + Mark Levis @HopkinsInHealth provide evidence of value in intl harmonization of tests & #bioinformatics [Track 1]
Image from Precision Medicine World Conference (@PMWCintl)
2
3
2017 Highlight: AMP hosted Online Corporate Workshops on #NGS-based clonality testing + #genomic aberration detection/interpretation challenges in #solidtumors. Download these FREE resources here: amp.org/education/amp-ed-onl… Thanks to our workshop sponsors, @Invivoscribe & @philips!
2
4
Last chance! Free @AMPath Workshop TODAY @ 12pm ET on #NGS-Based Clonality Testing. Sponsored by @Invivoscribe: ow.ly/pPHr30fFya1
Image from Association for Molecular Pathology (@AMPath)
3
4
FREE AMP Online Corporate Workshop - #NGS-Based Clonality Testing - Sponsored by @Invivoscribe - 10/10 @ 12pm ET ow.ly/pPHr30fFya1
Image from Association for Molecular Pathology (@AMPath)
1
2
Importance of Standardized Assays for #PrecisionMedicine with @Invivoscribe, @genection & @JohnsHopkins. #PMWC17 ow.ly/Kvae30bcuQF
2
2
#fightAML by knowing your risk factors #21April #AML #knowAML
Image from Know AML 🔴⚫️ (@KNOW_AML)
3
5
.@Novartis’ #acute #myeloid #leukaemia #drug granted @US_FDA priority review bit.ly/2gqc4vQ #aml @Invivoscribe
Image from European Pharmaceutical Review (@PharmaReview)
1
J.Miller CEO @Invivoscribe discusses oncology #biomarker tests @ #PMWC16 CancerDx #NGS #immunooncology #liquidbiopsy ow.ly/10gGTR
1
1
Invivoscribe retweeted
Biocom (@Biocom) profile picture
Biocom
@Biocom4 Apr 2016
.@Invivoscribe is developing CDx, MRD tests for acute myeloid #leukemia; @US_FDA clearance. bit.ly/1MHlsp5
3
2
Invivoscribe retweeted
HemOnc Today (@HemOncToday) profile picture
HemOnc Today@HemOncToday1 Mar 2016
Top Takeaways from @ASH_hematology: Midostaurin improves OS, EFS in FLT3-mutated AML goo.gl/1BGCpM #leukemia
1
1
#askMMRF No.1 - "What is multiple myeloma?" #MyelomaAwarenessMonth
Image from Multiple Myeloma RF (@theMMRF)
1
33
13
Invivoscribe retweeted
genection (@genection) profile picture
genection@genection19 Nov 2015
Excited to be exhibiting at #ASH2015 Booth #324. Come see how we are helping doctors and pharma improve treatments for heme diseases
1
1
Missed out on #AMP2015? You can still read the JMD special compendium at digitaleditions.sheridan.com…
Image from The Journal of Molecular Diagnostics (@JMDiagn)
1
Invivoscribe retweeted
genection (@genection) profile picture
genection@genection27 Oct 2015
Come see our Dr. @BradPatay talk about how we can better stratify & diagnose patients with blood cancers at #AMP2015
Image from genection (@genection)
2
3
Watch this CAP video: Instrument's Calibration in the Clinical Laboratory: Impact on patient care bit.ly/1PpIugn via @YouTube
2
1
Load more